ReP USP - Resultado da busca

Artigo de periodico
Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia (2020)
Oliveira, Milena Locci de ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Pippa, Leandro Francisco ; Simões, Belinda Pinto ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Milena Locci de et al. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, v. 191, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113576. Acesso em: 09 nov. 2024.
APA
Oliveira, M. L. de, Rocha, A., Nardotto, G. H. B., Pippa, L. F., Simões, B. P., & Lanchote, V. L. (2020). Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, 191, 1-8. doi:10.1016/j.jpba.2020.113576
NLM
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Vancouver
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Artigo de periodico
Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study (2016)
Castro, Francine Attié de; Scatena, Gabriel dos Santos; Rocha, Otávio Pelegrino; Marques, Maria Paula; Cass, Quézia Bezerra; Simões, Belinda Pinto; Lanchote, Vera Lúcia
Source: Journal of Chromatography B. Unidades: FMRP, FCFRP
Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS, REPRODUTIBILIDADE DE RESULTADOS, FARMACOCINÉTICA, REGRESSÃO LINEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study. Journal of Chromatography B, v. 1011, p. 53-61, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2015.12.049. Acesso em: 09 nov. 2024.
APA
Castro, F. A. de, Scatena, G. dos S., Rocha, O. P., Marques, M. P., Cass, Q. B., Simões, B. P., & Lanchote, V. L. (2016). Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study. Journal of Chromatography B, 1011, 53-61. doi:10.1016/j.jchromb.2015.12.049
NLM
Castro FA de, Scatena G dos S, Rocha OP, Marques MP, Cass QB, Simões BP, Lanchote VL. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1011 53-61.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jchromb.2015.12.049
Vancouver
Castro FA de, Scatena G dos S, Rocha OP, Marques MP, Cass QB, Simões BP, Lanchote VL. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1011 53-61.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jchromb.2015.12.049
Artigo de periodico
Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine (2016)
Castro, Francine Attié de; Simões, Belinda Pinto; Godoy, Ana Leonor Pardo Campos; Trigo, Fernanda Manuela Bertagnoli; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, v. 56, n. 12, p. 1555-1562, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.758. Acesso em: 09 nov. 2024.
APA
Castro, F. A. de, Simões, B. P., Godoy, A. L. P. C., Trigo, F. M. B., Coelho, E. B., & Lanchote, V. L. (2016). Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, 56( 12), 1555-1562. doi:10.1002/jcph.758
NLM
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/jcph.758
Vancouver
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/jcph.758
Artigo de periodico
Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients (2015)
Castro, Francine A. de; Piana, Chiara; Simões, Belinda Pinto; Lanchote, Vera Lúcia; Pasqua, Oscar Della
Source: British Journals of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, TRANSPLANTES, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine A. de et al. Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients. British Journals of Clinical Pharmacology, v. 80, n. 4, p. 618-629, 2015Tradução . . Disponível em: https://doi.org/10.1111/bcp.12648. Acesso em: 09 nov. 2024.
APA
Castro, F. A. de, Piana, C., Simões, B. P., Lanchote, V. L., & Pasqua, O. D. (2015). Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients. British Journals of Clinical Pharmacology, 80( 4), 618-629. doi:10.1111/bcp.12648
NLM
Castro FA de, Piana C, Simões BP, Lanchote VL, Pasqua OD. Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients [Internet]. British Journals of Clinical Pharmacology. 2015 ; 80( 4): 618-629.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1111/bcp.12648
Vancouver
Castro FA de, Piana C, Simões BP, Lanchote VL, Pasqua OD. Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients [Internet]. British Journals of Clinical Pharmacology. 2015 ; 80( 4): 618-629.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1111/bcp.12648

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em